Annual EBIT:
-$265.50M-$81.15M(-44.02%)Summary
- As of today, RYTM annual earnings before interest & taxes is -$265.50 million, with the most recent change of -$81.15 million (-44.02%) on December 31, 2024.
- During the last 3 years, RYTM annual EBIT has fallen by -$95.44 million (-56.12%).
- RYTM annual EBIT is now -3989.07% below its all-time high of -$6.49 million, reached on December 1, 2014.
Performance
RYTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$45.30M+$1.71M(+3.63%)Summary
- As of today, RYTM quarterly earnings before interest & taxes is -$45.30 million, with the most recent change of +$1.71 million (+3.63%) on June 30, 2025.
- Over the past year, RYTM quarterly EBIT has dropped by -$4.82 million (-11.90%).
- RYTM quarterly EBIT is now -14654.40% below its all-time high of -$307.00 thousand, reached on September 1, 2014.
Performance
RYTM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$177.44M-$4.82M(-2.79%)Summary
- As of today, RYTM TTM earnings before interest & taxes is -$177.44 million, with the most recent change of -$4.82 million (-2.79%) on June 30, 2025.
- Over the past year, RYTM TTM EBIT has increased by +$88.14 million (+33.19%).
- RYTM TTM EBIT is now -4470.84% below its all-time high of -$3.88 million, reached on September 1, 2015.
Performance
RYTM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RYTM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -44.0% | -11.9% | +33.2% |
| 3Y3 Years | -56.1% | -0.4% | +8.1% |
| 5Y5 Years | -81.8% | -41.9% | -30.7% |
RYTM EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -56.1% | at low | -15.3% | +67.6% | -2.8% | +34.7% |
| 5Y | 5-Year | -94.4% | at low | -32.1% | +67.6% | -30.8% | +34.7% |
| All-Time | All-Time | -3989.1% | at low | >-9999.0% | +67.6% | -4470.8% | +34.7% |
RYTM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$45.30M(+3.6%) | -$177.44M(-2.8%) |
| Mar 2025 | - | -$47.00M(-13.9%) | -$172.62M(+35.0%) |
| Dec 2024 | -$265.50M(-44.0%) | -$41.26M(+6.0%) | -$265.50M(+0.0%) |
| Sep 2024 | - | -$43.88M(-8.4%) | -$265.51M(+0.0%) |
| Jun 2024 | - | -$40.48M(+71.1%) | -$265.58M(+2.3%) |
| Mar 2024 | - | -$139.89M(-239.0%) | -$271.71M(-47.4%) |
| Dec 2023 | -$184.36M(-2.9%) | -$41.27M(+6.1%) | -$184.35M(+0.5%) |
| Sep 2023 | - | -$43.95M(+5.7%) | -$185.19M(-2.6%) |
| Jun 2023 | - | -$46.60M(+11.3%) | -$180.51M(-0.8%) |
| Mar 2023 | - | -$52.53M(-24.8%) | -$179.00M(+0.1%) |
| Dec 2022 | -$179.16M(-5.3%) | -$42.10M(-7.2%) | -$179.16M(+4.7%) |
| Sep 2022 | - | -$39.27M(+12.9%) | -$188.04M(+2.6%) |
| Jun 2022 | - | -$45.10M(+14.4%) | -$193.02M(-2.5%) |
| Mar 2022 | - | -$52.69M(-3.3%) | -$188.35M(-10.8%) |
| Dec 2021 | -$170.06M(-24.5%) | -$50.99M(-15.3%) | -$170.06M(-10.3%) |
| Sep 2021 | - | -$44.24M(-9.4%) | -$154.14M(-6.9%) |
| Jun 2021 | - | -$40.43M(-17.5%) | -$144.19M(-6.3%) |
| Mar 2021 | - | -$34.40M(+1.9%) | -$135.67M(+0.7%) |
| Dec 2020 | -$136.57M(+6.5%) | -$35.07M(-2.3%) | -$136.57M(-0.6%) |
| Sep 2020 | - | -$34.28M(-7.4%) | -$135.73M(+2.0%) |
| Jun 2020 | - | -$31.92M(+9.6%) | -$138.55M(+8.1%) |
| Mar 2020 | - | -$35.30M(-3.1%) | -$150.78M(-3.3%) |
| Dec 2019 | -$146.00M | -$34.22M(+7.8%) | -$146.00M(-5.1%) |
| Sep 2019 | - | -$37.11M(+16.0%) | -$138.93M(-14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$44.15M(-44.7%) | -$121.06M(-31.7%) |
| Mar 2019 | - | -$30.52M(-12.4%) | -$91.94M(-17.2%) |
| Dec 2018 | -$78.42M(-141.9%) | -$27.15M(-41.1%) | -$78.42M(-26.0%) |
| Sep 2018 | - | -$19.24M(-28.1%) | -$62.25M(-21.4%) |
| Jun 2018 | - | -$15.02M(+11.6%) | -$51.29M(-19.2%) |
| Mar 2018 | - | -$17.00M(-54.8%) | -$43.02M(-32.7%) |
| Dec 2017 | -$32.41M(-25.1%) | -$10.98M(-32.5%) | -$32.41M(-51.3%) |
| Sep 2017 | - | -$8.29M(-22.7%) | -$21.43M(-63.0%) |
| Jun 2017 | - | -$6.75M(-5.7%) | -$13.14M(-8.4%) |
| Mar 2017 | - | -$6.39M(-11.3%) | -$12.13M(+39.0%) |
| Dec 2016 | -$25.91M(-145.0%) | - | - |
| Jun 2016 | - | -$5.74M(-6.4%) | -$19.89M(-40.5%) |
| Mar 2016 | - | -$5.39M(+4.5%) | -$14.15M(-61.5%) |
| Dec 2015 | -$10.57M(-62.8%) | - | - |
| Dec 2015 | - | -$5.64M(-80.9%) | -$8.76M(-125.7%) |
| Sep 2015 | - | -$3.12M(-309.4%) | -$3.88M(+51.7%) |
| Dec 2014 | -$6.49M(+69.7%) | -$762.00K(-148.2%) | -$8.04M(-10.5%) |
| Sep 2014 | - | -$307.00K(+91.1%) | -$7.28M(-4.4%) |
| Jun 2014 | - | -$3.44M(+2.8%) | -$6.97M(+29.5%) |
| Mar 2014 | - | -$3.54M(+44.3%) | -$9.89M(+8.7%) |
| Dec 2013 | -$21.45M(-18.2%) | - | - |
| Jun 2013 | - | -$6.35M(-41.7%) | -$10.83M(-141.7%) |
| Mar 2013 | - | -$4.48M | -$4.48M |
| Dec 2012 | -$18.14M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of RYTM is -$265.50M
What is the all-time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$6.49M
What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, RYTM annual earnings before interest & taxes has changed by -$81.15M (-44.02%)
What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of RYTM is -$45.30M
What is the all-time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is -$307.00K
What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, RYTM quarterly earnings before interest & taxes has changed by -$4.82M (-11.90%)
What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of RYTM is -$177.44M
What is the all-time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$3.88M
What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, RYTM TTM earnings before interest & taxes has changed by +$88.14M (+33.19%)